Global Point of care (POC) Diagnostics Market Projection by Key Players, Share, Size, Trends, Segmentation Forecast – 2028
The global point of care (POC) diagnostics market size is projected to reach USD 36.21 billion by 2028, exhibiting a CAGR of -1.9% during the forecast period. The prevalence of several chronic disorders and the incorporation of nanotechnology in diagnostic kits are likely to fuel market growth. Fortune Business Insights™ provides this information in its report titled "Point of care (POC) Diagnostics Market, 2021-2028."
List of Key Players Profiled in the POC Diagnostics Market Report
·
F. Hoffmann-La Roche Ltd (Basel, Switzerland)
·
Thermo
Fisher Scientific Inc. (Massachusetts, U.S.)
·
Abbott
Laboratories (Illinois, U.S.)
·
Quest
Diagnostics Incorporated (New Jersey, U.S.)
·
BD
(Franklin Lakes, U.S.)
·
bioMérieux
SA (Marcy l'Etoile, France)
·
Cardinal
Health, Inc. (Ohio, U.S.)
·
Mesa
Biotech (California, U.S.)
·
Cepheid
(California, U.S.)
·
Trinity
Biotech (Bray, Ireland)
·
Quidel
Corporation (San Diego, U.S.)
·
Bio-Rad
Laboratories Inc. (California, U.S.)
Request for Free Sample Report PDF @ https://www.fortunebusinessinsights.com/enquiry/sample/point-of-care-diagnostics-market-101072
Impact of COVID-19
Robust Demand for Diagnostic Tools from Healthcare Sector to
Boost Market Progress
This market is likely to grow positively during the COVID-19
pandemic because of the rising demand for effective medical diagnostic tools
from the healthcare sector. Increasing COVID-19 cases and the emergence of
several organ failures is likely to fuel the product's demand. Increasing
investments in healthcare tools' development are likely to fuel diagnostics
tools' adoption. Manufacturers focus on incorporating stringent sanitization
methods and automated production techniques to avoid virus spread. Further, the
adoption of reduced capacities and part-time shifts may enable manufacturers to
control virus spread and recover losses. These factors are likely to fuel the
market growth during the pandemic.
Segments
By product type, the market is segmented into hematology
testing, pregnancy & infertility testing, cardiometabolic disease,
infectious disease, blood glucose monitoring, and others. As per end-user, it
is classified into homecare/self-testing, urgent care & retail clinics,
physician's office lab, and hospital bedside. Geographically, it is classified
into Europe, North America, Asia-Pacific, Latin America, and the Middle East
& Africa.
Drivers and Restraints
Developed Patient Based Treatment and Launch of Advanced
Diagnostic Solutions to Foster Growth
The rapid incline in chronic disorders is likely to fuel
demand for point of care (POC) diagnostics tools. As per the Centers for
Disease Control and Prevention (CDC)'s information nearly 115,045 syphilis
cases were reported in 2018. Heavy investments in the development of medical
and healthcare technology are likely to fuel the product's adoption.
Manufacturers focus on the development of patient-based treatment procedures to
improve the effectiveness of diagnostic procedures. For example, Abbott
launched its Afinion HbA1c Dx assay in June 2019 and is the first of its kind POC
diagnostics test that is approved by the U.S. Food and Drug Administration
(U.S. FDA) for diabetes diagnostics. In addition, the launch of advanced POC
diagnostic solutions is likely to attract significant demand. These factors are
likely to fuel point of care diagnostics market growth.
However, strict regulatory norms are expected to hinder the
progress of the market.
About
Us:
Fortune Business
Insights™ offers expert corporate analysis and accurate data, helping
organizations of all sizes make timely decisions. We tailor innovative
solutions for our clients, assisting them address challenges distinct to their
businesses. Our goal is to empower our clients with holistic market
intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis
to help companies achieve sustainable growth. Our team of experienced analysts
and consultants use industry-leading research tools and techniques to compile
comprehensive market studies, interspersed with relevant data.
Contact
Us:
Fortune Business Insights
Pvt. Ltd.
9th Floor, Icon Tower,
Baner - Mahalunge Road,
Baner, Pune-411045,
Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email:
mailto:sales@fortunebusinessinsights.com
Comments
Post a Comment